Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Fecal occult blood tests dominated the industry in 2016 owing to cost effectiveness and non-invasiveness as compared to colonoscopy and sigmoidoscopy. Immuno-FOB agglutination and Immuno-FOB ELISA tests are major revenue generating segments of fecal occult blood tests segment. Growing awareness along with rising demand for non-invasive cancer screening tests will further fuel business growth.
Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.
Market Analysis and Insights: Global Colorectal Cancer Diagnostic Market
In 2019, the global Colorectal Cancer Diagnostic market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Colorectal Cancer Diagnostic Scope and Market Size
Colorectal Cancer Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Colorectal Cancer Diagnostic market is segmented into Fecal Occult Blood Test, Biomarker Test, CRC DNA Screening Test, etc.
Segment by Application, the Colorectal Cancer Diagnostic market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, etc.
Regional and Country-level Analysis
The Colorectal Cancer Diagnostic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Colorectal Cancer Diagnostic market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Colorectal Cancer Diagnostic market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Colorectal Cancer Diagnostic business, the date to enter into the Colorectal Cancer Diagnostic market, Colorectal Cancer Diagnostic product introduction, recent developments, etc.
The major vendors include Abbott Molecular, Abbott, Beckman Coulter, Eiken Chemical, Epigenomics, Sysmex, Siemens Healthcare, Quest Diagnostics, CompanianDx, BioTime, Merck Millipore, GeneNews, BioMarCare, Immunostics, ExiQon, Mode Diagnostics, Randox, R-Biopharm, etc.
This report focuses on the global Colorectal Cancer Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Colorectal Cancer Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Abbott Molecular
Abbott
Beckman Coulter
Eiken Chemical
Epigenomics
Sysmex
Siemens Healthcare
Quest Diagnostics
CompanianDx
BioTime
Merck Millipore
GeneNews
BioMarCare
Immunostics
ExiQon
Mode Diagnostics
Randox
R-Biopharm
Fecal Occult Blood Test
Biomarker Test
CRC DNA Screening Test
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Colorectal Cancer Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Colorectal Cancer Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Colorectal Cancer Diagnostic are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Increasing incidences of colorectal cancer coupled with rising demand for non-invasive cancer screening tests will drive in-vitro colorectal cancer screening tests market over the forecast period. Growing geriatric population base, highly susceptible to suffer from colorectal cancer will further propel market growth.
Market Analysis and Insights: Global Colorectal Cancer Diagnostic Market
In 2019, the global Colorectal Cancer Diagnostic market size was US$ xx million and it is expected to reach US$ xx million by the end of 2026, with a CAGR of xx% during 2021-2026.
Global Colorectal Cancer Diagnostic Scope and Market Size
Colorectal Cancer Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Colorectal Cancer Diagnostic market is segmented into Fecal Occult Blood Test, Biomarker Test, CRC DNA Screening Test, etc.
Segment by Application, the Colorectal Cancer Diagnostic market is segmented into Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, etc.
Regional and Country-level Analysis
The Colorectal Cancer Diagnostic market is analysed and market size information is provided by regions (countries).
The key regions covered in the Colorectal Cancer Diagnostic market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Colorectal Cancer Diagnostic Market Share AnalysisColorectal Cancer Diagnostic market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Colorectal Cancer Diagnostic business, the date to enter into the Colorectal Cancer Diagnostic market, Colorectal Cancer Diagnostic product introduction, recent developments, etc.
The major vendors include Abbott Molecular, Abbott, Beckman Coulter, Eiken Chemical, Epigenomics, Sysmex, Siemens Healthcare, Quest Diagnostics, CompanianDx, BioTime, Merck Millipore, GeneNews, BioMarCare, Immunostics, ExiQon, Mode Diagnostics, Randox, R-Biopharm, etc.
This report focuses on the global Colorectal Cancer Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Colorectal Cancer Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Molecular
Abbott
Beckman Coulter
Eiken Chemical
Epigenomics
Sysmex
Siemens Healthcare
Quest Diagnostics
CompanianDx
BioTime
Merck Millipore
GeneNews
BioMarCare
Immunostics
ExiQon
Mode Diagnostics
Randox
R-Biopharm
Market segment by Type, the product can be split into
Fecal Occult Blood Test
Biomarker Test
CRC DNA Screening Test
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Colorectal Cancer Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Colorectal Cancer Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Colorectal Cancer Diagnostic are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
